.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...
.AbbVie has actually returned to the resource of its antipsychotic powerhouse Vraylar looking for an...
.GenSight Biologics is actually full weeks away from running out of amount of money. Again. The biot...
.Monopar Therapeutics is recouping a medication from the dump of AstraZeneca's uncommon health condi...
.Along with brand new information out on Arcus Biosciences' speculative HIF-2a prevention, one group...
.After developing a genetics therapy collaboration along with Dyno Therapies in 2020, Roche is back ...
.Lundbeck is lowering the book worth of its own $250 million Abide Rehabs buyout in reaction to peri...
.The assimilation of real-world data (RWD) into method workability as well as web site collection ha...
.At this year's Strong Biotech Peak in Boston ma, we caught up with forerunners in the biotech marke...
.Merck & Co. is actually taking down $30 million beforehand to acquire Yale spinout Modifi Biosci...
.Alpha-9 Oncology has elevated a $175 million set C round to money its clinical-stage radiopharmaceu...
.Eye medicine producer Ocuphire Pharma is actually acquiring genetics treatment programmer Opus Gene...
.Roche's severe coughing system has actually faltered to a standstill. The drugmaker, which axed the...
.Gilead Sciences and also Merck & Co. have actually guided their once-weekly HIV mix treatment pa...
.Lykos Rehabs might have lost three-quarters of its own team back the FDA's turndown of its own MDMA...
.Septerna may be actually as yet to make known "any kind of significant medical records," but the bi...
.AvenCell Therapeutics has actually protected $112 thousand in collection B funds as the Novo Holdin...
.China-based Minghui Drug has linked its thyroid eye disease therapy to a decrease in eye protruding...
.Sangamo Rehabs has actually identified a faster way to market for its Fabry ailment candidate, lini...
.Otsuka Drug's renal illness drug has hit the key endpoint of a phase 3 test by showing in an interi...